gefitinib has been researched along with choline in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (choline) | Trials (choline) | Recent Studies (post-2010) (choline) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 19,628 | 608 | 4,345 |
| Protein | Taxonomy | gefitinib (IC50) | choline (IC50) |
|---|---|---|---|
| Sodium- and chloride-dependent creatine transporter 1 | Rattus norvegicus (Norway rat) | 1.6 | |
| High affinity choline transporter 1 | Mus musculus (house mouse) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, N; Maeda, T; Minami, H; Oyabu, M; Sato, T; Tamai, I | 1 |
1 other study(ies) available for gefitinib and choline
| Article | Year |
|---|---|
Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells.
Topics: Animals; Antigens, CD; Cell Line, Tumor; Cells, Cultured; Choline; Gefitinib; Humans; Organic Cation Transport Proteins; Phosphatidylcholines; Pulmonary Alveoli; Pulmonary Surfactants; Quinazolines; Rats; Rats, Wistar | 2008 |